Thrombolysis should be regarded as first-line therapy for prosthetic valve thrombosis in the absence of contraindications [5] (multiple letters)

Journal of the American College of Cardiology

Volumn 45, Issue 2, 2005, Pages 325-326

  Lengyel, Maria ^a   Tong, Ann T ^c   Roudaut, Raymond ^c   Özkan, Mehmet ^c   Sagie, Alex ^c   Shahid, Maie S A ^c   Pontes Jr , Sergio C ^c   Carreras, Francesc ^c   Girard, Steven E ^c   Arnaout, Samir ^c   Stainback, Raymond F ^c   Thadani, Ravi ^c   Zoghbi, William A ^b  

^a Hungarian Institute of Cardiology   (Hungary)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; CARDIOPULMONARY HEMODYNAMICS; CONSENSUS DEVELOPMENT; DISEASE CLASSIFICATION; HEART VALVE PROSTHESIS; HUMAN; LETTER; MEDICAL ASSESSMENT; PATIENT MONITORING; PATIENT SELECTION; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

CORONARY THROMBOSIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART VALVE PROSTHESIS; HUMANS; THROMBOLYTIC THERAPY;

EID: 19944428709     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.10.028     Document Type: Letter

References (0)